Asia Pacific Gastrointestinal Drugs Market is expected to reach US$ 13,618.35 Mn in 2027

Published Date: 17 Nov 2020

Report : Asia Pacific Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

According to our new market research study on “Asia Pacific Gastrointestinal Drugs Market to 2027 – Regional Analysis and Forecast – by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 13,618.35 million by 2027 from US$ 8,868.44 million in 2019; it is estimated to grow at a CAGR of 5.6% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific gastrointestinal drugs market and the factors driving the market growth along with those hindering it.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing during the forecast period. The CAGR of the biologics segment has the highest CAGR in the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

The growth of the Asia Pacific Gastrointestinal Drugs market is mainly attributed to rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics. However, low awareness associated with gastrointestinal disorders in low-income economies will restrict the market growth.

GlaxoSmithKline plc; Celltrion Healthcare Co., Ltd.; Johnson and Johnson Services, Inc.; AstraZeneca; and Takeda Pharmaceutical Company Limited are among the leading companies operating in the Asia Pacific Gastrointestinal Drugs market.

The Report Segments Asia Pacific Gastrointestinal Drugs Market as Follows:

Asia Pacific Gastrointestinal Drugs Market – By Drug Class

  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others

Asia Pacific Gastrointestinal Drugs Market – By Route of Administration

  • Oral
  • Parenteral

Asia Pacific Gastrointestinal Drugs Market – By Application

  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others

Asia Pacific Gastrointestinal Drugs Market – By Country

  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of APAC

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Download PDF Brochure